Search and Browse
Download
Enter Data
| Reaction Details | |||
|---|---|---|---|
 | Report a problem with these data | ||
| Target | Serine/threonine-protein kinase mTOR | ||
| Ligand | BDBM315482 | ||
| Substrate/Competitor | n/a | ||
| Meas. Tech. | In vitro kinase assay | ||
| IC50 | <100±n/a nM | ||
| Citation |  Liu, Y; Ren, P; Jessen, K; Guo, X; Rommel, C Combination pharmaceutical compositions and uses thereof US Patent US10172858 Publication Date 1/8/2019 | ||
| More Info.: | Get all data from this article, Assay Method | ||
| Serine/threonine-protein kinase mTOR | |||
| Name: | Serine/threonine-protein kinase mTOR | ||
| Synonyms: | FK506-binding protein 12-rapamycin complex-associated protein 1 | FKBP12-rapamycin complex-associated protein | FRAP | FRAP 1 (mTOR) | FRAP1 | FRAP2 | MTOR | MTOR_HUMAN | Mammalian Target of Rapamycin (mTOR) | P42345 | RAFT1 | RAPT1 | Rapamycin and FKBP12 target 1 | Rapamycin target protein | Serine/threonine-protein kinase (mTOR) | mTORC2 | ||
| Type: | Rapamycin target protein | ||
| Mol. Mass.: | 288917.12 | ||
| Organism: | Homo sapiens (Human) | ||
| Description: | P42345 | ||
| Residue: | 2549 | ||
| Sequence: |
| ||
| BDBM315482 | |||
| n/a | |||
| Name | BDBM315482 | ||
| Synonyms: | US10172858, Table 1.6 | ||
| Type | Small organic molecule | ||
| Emp. Form. | C22H26N8O2 | ||
| Mol. Mass. | 434.4942 | ||
| SMILES | Nc1nc2cc(ccc2o1)-c1nn(C2CCC(CC2)N2CCOCC2)c2ncnc(N)c12 |(4.74,8.63,;3.41,7.86,;3.41,6.32,;1.95,5.84,;1.32,4.44,;-.21,4.28,;-1.12,5.52,;-.49,6.93,;1.04,7.09,;1.95,8.34,;-.61,2.79,;.29,1.54,;-.61,.3,;-.21,-1.19,;-1.3,-2.28,;-.9,-3.77,;.58,-4.17,;1.67,-3.08,;1.27,-1.59,;.98,-5.65,;-.11,-6.74,;.29,-8.23,;1.78,-8.63,;2.87,-7.54,;2.47,-6.05,;-2.08,.77,;-3.41,0,;-4.74,.77,;-4.74,2.31,;-3.41,3.08,;-3.41,4.62,;-2.08,2.31,)| | ||
| Structure | 
| ||